Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04468386 · ClinicalTrials.gov registry record
Specimen Collection Study Protocol
A clinical trial, sponsored by Biomerica.
- Completed
- Registry status
- 47
- Enrollment target
NCT04468386 is a clinical trial that has completed, run by Biomerica. The registered enrollment target is 47 participants.
The verdict
NCT04468386 has completed, sponsored by Biomerica.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
The specimens collected will be used to evaluate matrix equivalency in an immunoassay in development for the detection of IgG or IgA or IgM antibodies to SARS - CoV2 in human serum. These reagents are for in vitro diagnostic use only.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2021-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04468386
The ClinicalTrials.gov registry entry for NCT04468386 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomerica, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04468386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04468386 about?
NCT04468386 is a clinical study titled "Specimen Collection Study Protocol". The specimens collected will be used to evaluate matrix equivalency in an immunoassay in development for the detection of IgG or IgA or IgM antibodies to SARS - CoV2 in human serum. These reagents are for in vitro diagnostic use only.
What is the current status of trial NCT04468386?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2020-07-07. Estimated completion is 2021-05-30.
Who is sponsoring clinical trial NCT04468386?
This trial is sponsored by Biomerica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.